Mazor Robotics Ltd. (NASDAQ:MZOR) – Stock analysts at First Analysis lifted their Q3 2016 earnings per share estimates for Mazor Robotics in a research report issued on Thursday. First Analysis analyst G. Chodaczek now anticipates that the brokerage will post earnings per share of ($0.16) for the quarter, up from their previous estimate of ($0.20). First Analysis also issued estimates for Mazor Robotics’ Q4 2016 earnings at ($0.06) EPS, FY2016 earnings at ($0.61) EPS, Q1 2017 earnings at ($0.12) EPS, Q2 2017 earnings at ($0.07) EPS and FY2017 earnings at ($0.25) EPS.
Several other research firms also recently weighed in on MZOR. Barclays PLC upped their price target on Mazor Robotics from $24.00 to $28.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 11th. Zacks Investment Research upgraded Mazor Robotics from a “sell” rating to a “hold” rating and set a $22.00 price target on the stock in a research note on Tuesday, July 19th. B. Riley initiated coverage on Mazor Robotics in a research note on Tuesday, October 11th. They issued a “neutral” rating and a $25.00 price target on the stock. Needham & Company LLC restated a “hold” rating on shares of Mazor Robotics in a research note on Wednesday, October 12th. Finally, Standpoint Research initiated coverage on Mazor Robotics in a research note on Friday, July 8th. They issued a “buy” rating and a $30.00 price target on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the stock. Mazor Robotics has a consensus rating of “Hold” and a consensus price target of $26.25.
Mazor Robotics (NASDAQ:MZOR) opened at 23.22 on Monday. Mazor Robotics has a 12 month low of $8.31 and a 12 month high of $26.55. The company has a 50 day moving average price of $23.40 and a 200 day moving average price of $18.61. The firm’s market capitalization is $503.25 million.
Mazor Robotics (NASDAQ:MZOR) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.11) by $0.02. Mazor Robotics had a negative return on equity of 42.30% and a negative net margin of 60.75%. The business earned $8.30 million during the quarter, compared to analyst estimates of $8.51 million. During the same period in the previous year, the firm earned ($0.05) EPS. Mazor Robotics’s quarterly revenue was up 6.4% compared to the same quarter last year.
A number of hedge funds have recently modified their holdings of MZOR. Iguana Healthcare Management LLC increased its stake in shares of Mazor Robotics by 60.0% in the second quarter. Iguana Healthcare Management LLC now owns 200,000 shares of the company’s stock valued at $3,596,000 after buying an additional 75,000 shares in the last quarter. Menta Capital LLC increased its stake in shares of Mazor Robotics by 25.0% in the second quarter. Menta Capital LLC now owns 46,848 shares of the company’s stock valued at $842,000 after buying an additional 9,366 shares in the last quarter. EAM Investors LLC acquired a new stake in shares of Mazor Robotics during the second quarter valued at approximately $2,348,000. Cookson Peirce & Co. Inc. acquired a new stake in shares of Mazor Robotics during the second quarter valued at approximately $192,000. Finally, Candriam Luxembourg S.C.A. acquired a new stake in shares of Mazor Robotics during the second quarter valued at approximately $1,079,000. Institutional investors and hedge funds own 18.72% of the company’s stock.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.